ARCHIVES

Amgen Replaces “Bundling” Contract With Three Separate Contracts For Growth Factors.

This article is from The Cancer Letter archive.

Vol. 34 No. 32 | September 5, 2008

Download PDF Visit The Full Archive

Related Articles

NCI Suspend Tulane, LSU From Accrual Due To Missing Data

April 29, 1994

Spending Freeze Could Harm Medical Research, ACS Advocacy Affiliate Says

January 29, 2010

Study: Vismodegib Effective Where Surgery is Inappropriate

June 24, 2011

Randomized Trial Finds Supplement Use Didn’t Prevent Prostate Cancer After 5 Years.

October 31, 2008

FDA Plans to Discuss the Negative Trial of AstraZeneca’s Drug Iressa With the Oncologic Drugs Advisory Committee in March.

January 21, 2005

Clinical Trials Approved By NCI CTEP Last Month

July 29, 2011